AstraZeneca vaccine: Status report on which countries are using and which ones are suspending

Factbox: Some countries limit AstraZeneca vaccine use amid concern over rare blood clots Some countries are restricting use of the AstraZeneca vaccine against COVID-19 while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue. Reuters Staff U.S.

(Reuters) - Some countries are restricting use of the AstraZeneca vaccine against COVID-19 while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.

The European Medicines Agency (EMA) and the World Health Organization (WHO) have said the benefits of the shot outweigh the risks, but are monitoring the developing situation as more cases are reported.

AstraZeneca, an Anglo-Swedish company, said earlier in March its vaccine was 76% effective in preventing symptomatic coronavirus infections in a U.S. trial, and that studies did not indicate higher risks of clotting.

Below are two lists in alphabetical order: the first shows countries and regions which have resumed using the vaccine – some with restrictions by age - after the investigations, and the second lists shows suspensions still in place. 

...